Bioequivalence and Bioavailability Forum

Subject	Author	Posted	Rep.	last R.	Views
BE parallel design BE parallel design BE parallel design BE parallel design a posteriori power... a posteriori power... a posteriori power... a posteriori power...	Sathya	2008-09-06 06:46	7	2008-09-10 07:49	11,881
Pharmacokinetic calculation in missing samples	drplacebo	2008-11-10 09:05	0		5,236
failed bioequivalence study failed bioequivalence study	A-M-R	2009-05-24 13:47	1	2009-05-24 12:48	6,047
Missing samples in terminal elimination phase Missing samples in terminal elimination phase Missing samples in terminal elimination phase Missing samples in terminal elimination phase Missing samples in terminal elimination phase	Bhupesh	2009-10-12 14:14	4	2009-10-13 16:24	10,438
drug concentration nil in both periods drug concentration <LLOQ in both periods drug concentration <LLOQ in both periods drug concentration <LLOQ in both periods drug concentration <LLOQ in both periods drug concentration <LLOQ in both periods	VP	2009-10-14 09:10	5	2009-10-15 12:13	7,663
Inadequate Concentrations Inadequate Concentrations Inadequate Concentrations Inadequate Concentrations	kiranActimus	2010-02-18 09:00	3	2010-03-12 08:10	6,773
Pre-dose concentrations in period 2 Pre-dose concentrations in period 2 Pre-dose concentrations in period 2	Averroes	2011-02-22 14:05	2	2011-02-22 17:14	6,583
Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study… Redosing study…	H.Patel	2011-06-15 16:28	11	2011-06-18 09:53	14,708
Pre Treatment drug levels Pre Treatment drug levels Pre Treatment drug levels Protocol Deviation	JOI	2011-11-16 11:57	3	2011-11-16 17:11	8,253
pre-dose concentrations above LLOQ pre-dose concentrations above LLOQ pre-dose concentrations above LLOQ pre-dose concentrations above LLOQ pre-dose concentrations above LLOQ pre-dose concentrations above LLOQ	Paola	2011-12-21 12:58	5	2011-12-22 21:06	10,324
Predose concentration more than 5 % of Cmax Exclusion of subjects (predose >5 % of Cmax)	kamblpa1	2011-12-27 05:19	1	2011-12-27 17:35	9,365
Statistical Out come Statistical Out come Statistical Out come	auditor	2012-02-01 12:58	2	2012-02-02 18:13	6,251
To calculate AUC0-inf in Scaled average bioequivalence Completely lost sequence in partial replicate	aquapurple	2012-08-24 11:50	1	2012-08-24 18:07	6,333
First point Cmax First point Cmax First point Cmax First point Cmax First point Cmax	auditor	2012-02-10 06:50	4	2012-09-10 11:54	11,279
high concentration in the elimination phase-Metaxalone high concentration in the elimination phase-Metaxalone high concentration in the elimination phase-Metaxalone Enterohepatic recirculation Enterohepatic recirculation Enterohepatic recirculation high concentration in the elimination phase-Metaxalone high concentration in the elimination phase-Metaxalone high concentration in the elimination phase-Metaxalone	cakhatri	2012-09-07 05:58	8	2012-09-14 04:30	12,785